Critical pharma facilities, cancer treatments, and COVID tests
Maryland has long been a hotbed for the nation’s fast-growing biotechnology and biomanufacturing industries due to the state’s high concentration of doctoral scientists and engineers, proximity to federal health agencies, and many tax incentives.
Speed to market is crucial for biomanufacturing companies seeking to gain a foothold in the area and maintain a competitive advantage. The coronavirus added another layer of complexity and urgency to various construction projects, especially for companies manufacturing life-saving pharmaceutical products.